Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (171-180 of 368) with videos related to

Pageof 37
Sort By:
The International Journal on Drug Policy|July 27, 2020
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysisLucy Thi Tran, Amy Peacock, Samantha Colledge, et al.
Addiction (Abingdon, England)|December 21, 2019
Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in AustraliaBriony Larance, Louisa Degenhardt, Jason Grebely, et al.
Journal of Gastroenterology and Hepatology|July 25, 2007
Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug usersJason Grebely, Jesse D Raffa, Caite Meagher, et al.
The International Journal on Drug Policy|February 12, 2019
Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugsEmma Day, Tina Broder, Julie Bruneau, et al.
The Journal of Infectious Diseases|January 30, 2020
Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to DiagnosisJason Grebely, Beth Catlett, Indika Jayasinghe, et al.
Lancet (London, England)|October 29, 2019
Global patterns of opioid use and dependence: harms to populations, interventions, and future actionLouisa Degenhardt, Jason Grebely, Jack Stone, et al.
Drug and Alcohol Dependence|March 27, 2007
The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy programJesse D Raffa, Jason Grebely, Harout Tossonian, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2007
Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy programHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2010
Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer supportJason Grebely, Elizabeth Knight, Krista A Genoway, et al.
Hepatology (Baltimore, Md.)|September 18, 2016
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II studyMarianne Martinello, Edward Gane, Margaret Hellard, et al.
Pageof 37

Showing results (171-180 of 368) with videos related to

Sort By:
Pageof 37
The International Journal on Drug Policy|July 27, 2020
Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysisLucy Thi Tran, Amy Peacock, Samantha Colledge, et al.
Addiction (Abingdon, England)|December 21, 2019
Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in AustraliaBriony Larance, Louisa Degenhardt, Jason Grebely, et al.
Journal of Gastroenterology and Hepatology|July 25, 2007
Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug usersJason Grebely, Jesse D Raffa, Caite Meagher, et al.
The International Journal on Drug Policy|February 12, 2019
Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugsEmma Day, Tina Broder, Julie Bruneau, et al.
The Journal of Infectious Diseases|January 30, 2020
Time to Detection of Hepatitis C Virus Infection With the Xpert HCV Viral Load Fingerstick Point-of-Care Assay: Facilitating a More Rapid Time to DiagnosisJason Grebely, Beth Catlett, Indika Jayasinghe, et al.
Lancet (London, England)|October 29, 2019
Global patterns of opioid use and dependence: harms to populations, interventions, and future actionLouisa Degenhardt, Jason Grebely, Jack Stone, et al.
Drug and Alcohol Dependence|March 27, 2007
The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy programJesse D Raffa, Jason Grebely, Harout Tossonian, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 1, 2007
Methadone dosing strategies in HIV-infected injection drug users enrolled in a directly observed therapy programHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2010
Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer supportJason Grebely, Elizabeth Knight, Krista A Genoway, et al.
Hepatology (Baltimore, Md.)|September 18, 2016
Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II studyMarianne Martinello, Edward Gane, Margaret Hellard, et al.
Pageof 37